Biologicals Acting Against Interleukin 1 May Reduce Corticosteroid Dependence in Systemic Onset Juvenile Idiopathic Arthritis

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-9-s1-p70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

MEFV Mutations in Iranian Children With Systemic Onset Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Whole Exome Sequencing in Systemic Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Systemic Juvenile Idiopathic Arthritis in the Republic of Bashkortostan

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Editorial: Interferon-Γ: Friend or Foe in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease?

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2014English

Population Pharmacokinetics of Tacrolimus in Pediatric Patients With Systemic‑onset Juvenile Idiopathic Arthritis: Initial Dosage Recommendations

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

The TLR4 Ligands MRP8 and MRP14 in the Diagnosis and Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Juvenile Idiopathic Arthritis

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy